Literature DB >> 10449608

Organised vs. spontaneous Pap-smear screening for cervical cancer: A case-control study.

P Nieminen1, M Kallio, A Anttila, M Hakama.   

Abstract

To compare the effect of organised pap-smear screening for cervical cancer with that of the spontaneous one on the incidence of invasive cervical cancer, we performed a case-control study within the catchment area of the Helsinki University Hospital (Helsinki, Finland). The study material consisted of 179 incident cases of invasive cervical cancer and 1,507 population controls. Data on lifetime pap smears before the year of the cancer diagnosis were collected using a self-administered questionnaire. The questionnaire information was obtained for 82% of the cases and 73% of the controls. The main outcome measure was relative risk of invasive cervical cancer among those with history of organised or spontaneous screening compared with risk among those with no history of screening for cervical cancer, measured as odds ratios (OR) with 95% confidence intervals (CI) and computed with logistic regression. Odds ratio of invasive cervical cancer among those who participated in the organised screening programme was 0.38 (CI 0.26-0.56) whereas any lifetime spontaneous pap smear had an OR value of 0.82 (CI 0. 53-1.26), in terms of unit risk for those not subjected to any screening and adjusted for age and the other type of the screening activity. Our results indicate that the substantial decrease in the incidence of and mortality due to cervical cancer in Finland is mainly due to the organised mass-screening. Copyright 1999 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  1999        PMID: 10449608     DOI: 10.1002/(sici)1097-0215(19990924)83:1<55::aid-ijc11>3.0.co;2-u

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  23 in total

1.  Organized breast cancer screening programs in Canada.

Authors:  A B Miller
Journal:  CMAJ       Date:  2000-10-31       Impact factor: 8.262

2.  Epidemiological aspects of cancer screening in Germany.

Authors:  Nikolaus Becker
Journal:  J Cancer Res Clin Oncol       Date:  2003-10-14       Impact factor: 4.553

Review 3.  [Screening from an epidemiologic perspective].

Authors:  N Becker
Journal:  Radiologe       Date:  2008-01       Impact factor: 0.635

4.  Recommendations on screening for cervical cancer.

Authors:  James Dickinson; Eva Tsakonas; Sarah Conner Gorber; Gabriela Lewin; Elizabeth Shaw; Harminder Singh; Michel Joffres; Richard Birtwhistle; Marcello Tonelli; Verna Mai; Meg McLachlin
Journal:  CMAJ       Date:  2013-01-07       Impact factor: 8.262

Review 5.  Centralisation of services for gynaecological cancer.

Authors:  Yin Ling Woo; Maria Kyrgiou; Andrew Bryant; Thomas Everett; Heather O Dickinson
Journal:  Cochrane Database Syst Rev       Date:  2012-03-14

6.  Age-period-cohort analysis of cervical cancer incidence in Hong Kong from 1972 to 2001 using maximum likelihood and Bayesian methods.

Authors:  Gabriel M Leung; Pauline P S Woo; Sarah M McGhee; Annie N Y Cheung; Susan Fan; Oscar Mang; Thuan Q Thach; Hextan Y S Ngan
Journal:  J Epidemiol Community Health       Date:  2006-08       Impact factor: 3.710

Review 7.  Cervical cancer screening.

Authors:  Dorothy J Wiley; Bradley J Monk; Emmanuel Masongsong; Kristina Morgan
Journal:  Curr Oncol Rep       Date:  2004-11       Impact factor: 5.075

8.  Cytology use for cervical cancer screening in Portugal: results from the 2005/2006 National Health Survey.

Authors:  Mariana Oliveira; Bárbara Peleteiro; Nuno Lunet
Journal:  Eur J Public Health       Date:  2013-06-20       Impact factor: 3.367

9.  Exposure Definition in Case-Control Studies of Cervical Cancer Screening: A Systematic Literature Review.

Authors:  Alejandra Castanon; Aruna Kamineni; K Miriam Elfström; Anita W W Lim; Peter Sasieni
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2021-09-14       Impact factor: 4.254

Review 10.  Screening for cervical cancer: a systematic review and meta-analysis.

Authors:  Leslea Peirson; Donna Fitzpatrick-Lewis; Donna Ciliska; Rachel Warren
Journal:  Syst Rev       Date:  2013-05-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.